Table 2 MethylCap-seq study characteristics.

From: Exploratory analysis of the human breast DNA methylation profile upon soymilk exposure

ID

Treatment

Coverage

Mapped

% Mapped

Library size

SB1

Soymilk

23641310

15130395

64.00%

3230581

SB2

Soymilk

20005124

13364407

66.80%

2344832

SB3

Soymilk

20596052

13283325

64.49%

3120649

SB4

Soymilk

23605776

16486437

69.84%

2402701

SB5

Control

52472379

36240165

69.07%

4747398

SB6

Control

28784091

19727820

68.54%

2826594

SB7

Control

50403081

34620817

68.69%

4832033

SB8

Soymilk

32235327

22806551

70.75%

3336655

SB9

Control*

30410592

21433945

70.48%

NA

SB10

Control

47379658

33209046

70.09%

4353299

SB11

Soymilk

33798425

24635918

72.89%

1859969

SB12

Control

32412829

22138492

68.30%

3408381

SB13

Control

28898463

19854562

68.70%

3212742

SB14

Control

26743842

18134534

67.81%

3319438

SB15

Control

30217735

19679085

65.12%

4302979

SB16

Soymilk

21840292

14934423

68.38%

2837047

SB17

Soymilk*

25667328

18073389

70.41%

NA

SB18

Soymilk

24902261

15842246

63.62%

4044801

SB19

Soymilk

28582845

20225632

70.76%

2789297

SB20

Control

29028050

19954925

68.74%

3169451

SB21

Control*

32123694

21969096

68.39%

3446305

SB22

Soymilk*

30182885

20833618

69.02%

2894860

  1. Columns represent id, coverage (amount of sequenced paired-end fragments), amount and fraction of mapped fragments, and final library sizes of data used for limma-voom statistical analysis. *Technical replicates, replicates with lowest coverage were not considered for statistical analysis (therefore “NA” for library size).